GlassScriptPhysician profile
Gaurav Jain
NPI 1750584843
$18,792.65
in general payments reported to CMS, 2019-2025
12 companies · $1,119 in 2025
The $1,119 reported for 2025 was more than what 80% of Nephrology (Internal Medicine) providers received nationally (typical 2025 total: $311).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $239 · 2021: $19.16 · 2022: $2,120 · 2023: $292 · 2024: $15K · 2025: $1,119.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $11K · Travel and Lodging: $2,999 · Food and Beverage: $1,783 · Compensation For Serving As Faculty Or As A Speaker For A Medical Education Program: $450.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $11,182.50 |
| Travel and Lodging | $2,999.28 |
| Food and Beverage | $1,783.05 |
| Compensation For Serving As Faculty Or As A Speaker For A Medical Education Program | $450.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novo Nordisk INC | $11,750.36 | 2024-2025 | |
| Fresenius USA Marketing, INC. | $2,370.09 | 2021-2024 | Velphoro |
| Outset Medical INC | $2,000.00 | 2022 | |
| Amgen INC. | $1,712.64 | 2023-2025 | Tavneos, Krystexxa |
| Nxstage Medical, INC. | $237.59 | 2025 | Nxstage System One, Liberty Select Cycler |
| Vantive US Healthcare LLC | $166.22 | 2025 | Renal - Acute, Renal - Pd |
| Baxter Healthcare | $140.37 | 2022-2024 | Renal - Pd |
| Boehringer Ingelheim Pharmaceuticals, INC. | $125.00 | 2019 | |
| Alexion Pharmaceuticals, INC. | $100.00 | 2019 | |
| Glaxosmithkline, LLC. | $88.17 | 2022-2025 | Benlysta, Jesduvroq |
| Xeris Pharmaceuticals, INC. | $88.06 | 2023 | Gvoke Hypopen |
| Vifor Pharma, INC. | $14.15 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Gaurav Jain listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.